// App-Quantinova.ai

DXT56 : Relapse Outcomes in Clarity EXT Patients Treated with Cladribine Tablets or Placebo Were Comparable Regardless of the between-Trial Bridging Intervals

Researchers

Presenter

  • Kottil Rammohan

Principal Investigators

  • Doris Damian

  • Yann Hyvert

  • Fernando Dangond

  • Lori Lebson

  • Gavin Giovannoni

Medical Centers

  • Ohio State University Hospital

  • Queen Mary University, London, UK

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Exostosin Glycosyltransferase 1

Drug/Treatment

  • Cladribine

Outcome

  • N/A

Study Design

  • Placebo Control

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved